BeOne Medicines Ltd. (ONC)
Data as of September 10, 2026 · Medical - Pharmaceuticals
Stockbruh grade: Strong 4/5 metrics rated Sunny
What does BeOne Medicines Ltd. do?
🔬 BeiGene, Ltd. is an oncology company that discovers and develops treatments for cancer patients around the world. They offer innovative products like BRUKINSA, a cool molecule that kicks cancer's butt, and TEVIMBRA, an anti-PD-1 immunotherapy that fights tumors with style. Headquartered in Camana Bay, Cayman Islands, they are on a mission to bring hope to cancer patients globally! 🌍🧪.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $351.48 | Market Cap | — |
| Exchange | NASDAQ Global Market | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
Are they building the future?
Revenue and earnings are trending upward — BeOne Medicines Ltd. appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.